Strides Pharma gets USFDA nod for generic medication
Strides Pharma Science on Tuesday said its subsidiary has received approval from the US health regulator to market a generic medication for seizures.
![Strides Pharma gets USFDA nod for generic medication](https://cdn.zeebiz.com/sites/default/files/2023/11/21/269781-strides-pharma-1.jpg?im=FitAndFill=(1200,900))
Singapore-based Strides Pharma Global Pte Ltd has received approval for Levetiracetam Oral Solution USP, 100 mg/mL, from the US Food & Drug Administration (USFDA), the company said in a regulatory filing. Image Source: strides.com